patentstorm.us 258 85 http://www.patentstorm.us/ http://www.patentstorm.us/images/logo.gif PatentStorm -> Applications -> Organic compounds -- part of the class 532-570 series http://www.patentstorm.us/rss/class/applications/rss-564.xml Recent patent applications filings in USPTO Class 564 Organic compounds -- part of the class 532-570 series. Thu, 18 Mar 2010 15:01:28 patents@patentstorm.us en <![CDATA[GARLIC PROCESSING]]> http://www.patentstorm.us/applications/20100069674/description.html
  • Application Number:  20100069674
  • Publication Date:  2010-03-18
  • Inventors:  Block, Eric; Groom, Murree
    • A method of producing polysulfides comprising the step of adding elemental sulphur to an allicin-containing plant extract. In preferred embodiments, the plant extract is mechanically treated members of the genus Allium, especially garlic. In further preferred aspects of the invention, the plant extract and sulphur mixture is heated, and the pH is controlled to allow manipulation of the polysulfide chain length. The addition of organic bases, containing nitrogen lone pairs, allows further ...
    ]]>     20100069674     <![CDATA[Neutralization of Ethylenediamine Hydrochloride and recovery of Ethylenediamine]]> http://www.patentstorm.us/applications/20100069673/description.html
  • Application Number:  20100069673
  • Publication Date:  2010-03-18
  • Inventors:  Cesas, Romas; Zajack, Theodore
    • In a neutralization and recovery process ethylene diamine hydrochloride (EDA-HCL) is neutralized and ethylene diamine (EDA) is recovered using a mixture of solid caustic dissolved in a non-aqueous solvent, for example an ...
    ]]>     20100069673     <![CDATA[HIGH FUNCTIONALITY AMINE COMPOUNDS AND USES THEREFOR]]> http://www.patentstorm.us/applications/20100069672/description.html
  • Application Number:  20100069672
  • Publication Date:  2010-03-18
  • Inventors:  Renken, Terry L.; Burton, Bruce L.
    • In another exemplary embodiment, an amine functional curing agent has an Amine Hydrogen Functionality (AHF) of at least 7 and an Amine-Hydrogen Equivalent Weight (AHEW) of at least about ...
    ]]>     20100069672     <![CDATA[Process For Preparing Polyetheramines]]> http://www.patentstorm.us/applications/20100069671/description.html
  • Application Number:  20100069671
  • Publication Date:  2010-03-18
  • Inventors:  Raab, Klaus; Wachsen, Olaf; Buehring, Dirk; Gallas, Andreas; Scherl, Franz-Xaver
    • The invention provides a process for preparing polyetheramines of the formula (1), R2 (NR1R3)n, in which n is a number from 1 to 20, R2 represents an organic radical that contains between 2 and 600 oxalkylene groups, and R1 and R3 are alike or different and represent hydrogen or an organic radical having 1 to 400 carbon atoms, by combining a compound of the formula (2), H(NR1R3), with a compound ...
    ]]>     20100069671     <![CDATA[Oxidation catalyst]]> http://www.patentstorm.us/applications/20100069670/description.html
  • Application Number:  20100069670
  • Publication Date:  2010-03-18
  • Inventor:  Suzuki, Ken
    • An oxidation catalyst for use in the oxidation of a substrate with a molecular oxygen, comprising at least one member selected from the group consisting of a specific hydrazyl radical (such as 2,2-diphenyl-1-picrylhydrazyl) and a specific hydrazine compound (such as 2,2-diphenyl-1-picrylhydrazine). A method for producing a chemical compound, comprising contacting a substrate with a molecular oxygen in the presence of the above-mentioned oxidation ...
    ]]>     20100069670     <![CDATA[Preparation of Iodixanol]]> http://www.patentstorm.us/applications/20100069669/description.html
  • Application Number:  20100069669
  • Publication Date:  2010-03-18
  • Inventor:  Homestad, Ole Magne
    • A process for the preparation of iodixanol by dimerisation of 5-acetamido-N,N′-bis(2,3-dihydroxypropy1)-2,4,6-triiodo-isophthalamide (“Compound A”) in which, after the dimerisation step, unreacted Compound A is precipitated from the reaction mixture and recovered for re-use. The process substantially increases the net yield of iodixanol and simplifies its ...
    ]]>     20100069669     <![CDATA[5-[(2R)-[2-[2-(2,2,2-TRIFLUOROETHOXY)PHENOXY]ETHYL]AMINO]PROPYL]-2-METHOXYBENZENESULFONAMIDE]]> http://www.patentstorm.us/applications/20100069668/description.html
  • Application Number:  20100069668
  • Publication Date:  2010-03-18
  • Inventors:  Zhong, Huijuan; Cen, Junda
    • 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide, a pharmaceutical composition containing the compound, and the synthesis method thereof. The compound has strong antagonism toward α1-adrenceptor and has high selectivity toward smooth muscle of urethra.

    ]]> 20100069668 <![CDATA[PLASTIC CRYSTAL]]> http://www.patentstorm.us/applications/20100069667/description.html

  • Application Number:  20100069667
  • Publication Date:  2010-03-18
  • Inventors:  Zhou, Zhi-Bin; Hajime, Matsumoto
    • The present invention relates to a conductor having high conductivity and electrochemical stability, which is in a solid state over a practically wide temperature range. Specifically disclosed is a plastic crystal containing a compound represented by Formula (I) or (IA) below:

    and at least one compound [BF3(CF3)] salt represented by Formula (II):


    ]]> 20100069667 <![CDATA[NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME]]> http://www.patentstorm.us/applications/20100069630/description.html

  • Application Number:  20100069630
  • Publication Date:  2010-03-18
  • Inventors:  Hyun, Young Lan; Cho, Joong Myung; Ro, Seong Gu; Lee, Cheol Hae; Jung, Hee Jung; Kim, Jae Hak; Jeong, Won Jang; Lee, Cheol Soon
    • The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell ...
    ]]>     20100069630     <![CDATA[PROCESS FOR PREPARING MATERIALS BY GRAFTING HALOGENATED PHOSPHORUS-CONTAINING GROUPS ONTO AN INORGANIC SURFACE]]> http://www.patentstorm.us/applications/20100069618/description.html
  • Application Number:  20100069618
  • Publication Date:  2010-03-18
  • Inventors:  Mutin, Hubert; Forestiere, Alain; Guerrero, Gilles; Chaumonnot, Alexandra; Revel, Renaud; Brodard-Severac, Florence
    • The invention concerns a process for preparing a hybrid organic-inorganic material (HOIM) with phosphorus-containing bridges between the surface of an inorganic substrate containing an element M and one or more organic groups of the covalent M-O-P-R type, said process using, as a precursor for said organic group or groups, at least one organophosphorus acid halide with formula RxP(O)Xy in which x=1 or 2, y=3−x, X being a halogen and R designating at least one organic ...
    ]]>     20100069618     <![CDATA[AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY]]> http://www.patentstorm.us/applications/20100069504/description.html
  • Application Number:  20100069504
  • Publication Date:  2010-03-18
  • Inventors:  Tarnus-Rondeau, Céline; Defoin, Albert; Albrecht, Sébastien; Maiereanu, Anamaria; Faux, Nadège; Pale, Patrick
    • A compound of the general formula (I) as an active principle for treating cancer, specifically tumors, in particular diseases involving inhibition of metalloproteases, such as Aminopeptidase-N. Pharmaceutical compositions comprising the compound of general formula (I). Methods of treatment using the compound of general formula ...
    ]]>     20100069504     <![CDATA[AMIDE COMPOUND AND USE THEREOF]]> http://www.patentstorm.us/applications/20100069499/description.html
  • Application Number:  20100069499
  • Publication Date:  2010-03-18
  • Inventors:  Komori, Takashi; Kubota, Mayumi; Matsuzaki, Yuichi
    • Disclosed is an amide compound represented by the formula (1) below, which has excellent plant disease controlling activity.

    In the formula, X1 represents a fluorine atom or a methoxy group; X2 represents a chlorine atom, a bromine atom, an iodine atom, a C1-C4 alkyl group or the like; Z represents an oxygen atom or a sulfur atom; and A represents an ...
    ]]> 20100069499 <![CDATA[SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION]]> http://www.patentstorm.us/applications/20100069484/description.html

  • Application Number:  20100069484
  • Publication Date:  2010-03-18
  • Inventor:  Vamvakides, Alexandre
    • The present invention involves new and original sigma receptors ligands : (Mono- or di-alkylaminoalkyl)-γ-butyrolactones, their analogues aminotetrahydrofuranes, the (1-adamantyl)phenyl(s) alkylamines, the N,N Dialkyl α-[(adamantyl-1)benzyloxy-2] alkylamines and the 3-cyclopentyl adamantyl-amines or alkylamines or -alkyl phenylamines, their enantiomers or diastereoisomers and their pharmaceutically acceptable salts, with pro-apoptotic and/or anti-apoptotic properties over cellular ...
    ]]>     20100069484     <![CDATA[BENZAMIDE DERIVATIVES AND USES RELATED THERETO]]> http://www.patentstorm.us/applications/20100069447/description.html
  • Application Number:  20100069447
  • Publication Date:  2010-03-18
  • Inventors:  Degraffenreid, Michael; Julian, Lisa; He, Xiao; McMinn, Dustin L.; Rew, Yosup; Yan, Xuelei; Sun, Daqing; POWERS, Jay P.
    • Benzamide derivatives of formulae I and II, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof, and pharmaceutical compositions comprising the same, are described and have therapeutic utility, particularly in the treatment of diabetes, obesity, and related conditions and disorders:

    wherein R1, R2, R3, R4, R5, R6, R7, ...
    ]]> 20100069447 <![CDATA[Use of Chk2 Kinase Inhibitors for Cancer Treatment]]> http://www.patentstorm.us/applications/20100069423/description.html

  • Application Number:  20100069423
  • Publication Date:  2010-03-18
  • Inventors:  Pommier, Yves; Shoemaker, Robert H.; Currens, Michael; Scudiero, Dominic; Cardellina, John; Jobson, Andrew
    • Described herein are Chk2-inhibitor compounds and derivatives thereof, and methods of treating or preventing disease and disease symptoms using the compounds and compositions ...
    ]]>     20100069423     <![CDATA[SUBSTITUTED INDANYL SULFONAMIDE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS]]> http://www.patentstorm.us/applications/20100069378/description.html
  • Application Number:  20100069378
  • Publication Date:  2010-03-18
  • Inventors:  Merce-Vidal, Ramon; Holenz, Joerg; Frigola-Constansa, Jordi; Lopez-Perez, Sara; Alcalde-Pais, Maria de las Ermitas; Mesquida-Estevez, Maria de les Neus
    • The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these ...
    ]]>     20100069378     <![CDATA[METHODS AND COMPOSITIONS FOR REVERSING P-GLYCOPROTEIN MEDICATED DRUG RESISTANCE]]> http://www.patentstorm.us/applications/20100068786/description.html
  • Application Number:  20100068786
  • Publication Date:  2010-03-18
  • Inventors:  Chmielewski, Jean A.; Hrycyna, Christine A.; Pires, Marcos M.
    • A method for inhibiting therapeutic drug resistance within a cell over-expressing a membrane protein is provided. The method comprises synthesizing a dimeric prodrug inhibitor of a monomeric therapeutic agent; administering the dimeric prodrug inhibitor to the membrane protein together with the monomeric therapeutic agent; and occupying at least one substrate binding site of the membrane protein with the synthesized dimeric prodrug to allow the monomeric therapeutic agent to accumulate within ...
    ]]>     20100068786     <![CDATA[METHOD FOR SCREENING ANTI-CANCER COMPOUNDS INHIBITING FUNCTION OF TM4SF5 AND ANTI-CANCER COMPOSITION CONTAINING CHALCONE COMPOUNDS]]> http://www.patentstorm.us/applications/20100068730/description.html
  • Application Number:  20100068730
  • Publication Date:  2010-03-18
  • Inventors:  PARK, Ki Hun; LEE, Jung Weon; RYU, Young Bae; RYU, Hyung Won; LEE, Sin-Ae
    • The present invention relates to a method for screening an anticancer compound and an anticancer compound screened using the method, and more particularly, to a method for screening an anticancer compound, the method comprising: culturing cancer cells expressing the oncogenic protein transmembrane 4 L6 family member 5 (TM4SF5), expressed as the polypeptide of SEQ ID NO: 2, treating the cancer cells with an anticancer candidate, and determining that the anticancer candidate is an anticancer ...
    ]]>     20100068730     <![CDATA[ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME]]> http://www.patentstorm.us/applications/20100068553/description.html
  • Application Number:  20100068553
  • Publication Date:  2010-03-18
  • Inventors:  Tosatti, Samuele; Zurcher, Stefan
    • The invention relates to a novel ultra-thin hydrophobic and oleophobic layer, formed by self-assembly on a solid substrate surface, of compounds of the general formula


    A-B

    in which
    A represents a group of the formula

      • ]]> 20100068553 <![CDATA[HYDROXYAMIDINE AND HYDROXYGUANIDINE COMPOUNDS AS UROKINASE INHIBITORS]]> http://www.patentstorm.us/applications/20100068272/description.html
      • Application Number:  20100068272
      • Publication Date:  2010-03-18
      • Inventors:  Buergle, Markus; Clement, Bernd; Schmalix, Wolfgang; Wosikowski, Katja; SPERL, Stefan
      The present invention relates to novel compounds for inhibiting the urokinase plasminogen activator (uPA), which have high bioavailability and oral administerability, and also to the use thereof as therapeutic active compounds for the treatment of urokinase- or/and urokinase receptor-associated disorders such as, for example, tumors and metastasizing. The invention relates in particular to compounds containing hydroxyamidine or hydroxyguanidine ...
      ]]> 20100068272 <![CDATA[BUPROPION HYDROBROMIDE POLYMORPHS]]> http://www.patentstorm.us/applications/20100068270/description.html
    • Application Number:  20100068270
    • Publication Date:  2010-03-18
    • Inventors:  TURCHETTA, Stefano; Zenoni, Maurizio
    Polymorphous and amorphous forms of bupropion hydrobromide are ...
    ]]>     20100068270     <![CDATA[Methods of radiofluorination of biologically active vectors]]> http://www.patentstorm.us/applications/20100068139/description.html
  • Application Number:  20100068139
  • Publication Date:  2010-03-18
  • Inventors:  Cuthbertson, Alan; Glaser, Matthias Eberhard; Solbakken, Magne; Karlsen, Hege; Arukwe, Joseph Maduabuchi
    • The invention relates to conjugates of formula (V) or (VI): wherein X is —CO—NH—, —NH—, —O—, —NHCONH—, or —NHCSNH—; their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.

    ]]> 20100068139 <![CDATA[METHOD OF OBTAINING 2-AMINO-6-ALKYL-AMINO-4,5,6,7- TETRAHYDROBENZOTHIAZOLES]]> http://www.patentstorm.us/applications/20100063324/description.html

  • Application Number:  20100063324
  • Publication Date:  2010-03-11
  • Inventors:  Pascual Coca, Gustavo; Martín Juárez, Jorge
    • The present invention relates to a process for preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles (I) wherein the asterisk (*) represents an asymmetric carbon and R1 is C1-C6 alkyl; their enantiomers or mixtures thereof, their solvates, hydrates or pharmaceutically acceptable salts, comprising: (a) reacting a compound (II) with a secondary amine, optionally in the presence of an acid and a solvent 1, to form an enamine; (b) optionally removing said ...
    ]]>     20100063324     <![CDATA[Reactor having titanium silicate recycling]]> http://www.patentstorm.us/applications/20100063323/description.html
  • Application Number:  20100063323
  • Publication Date:  2010-03-11
  • Inventors:  BAUMGARTEN, Goetz; ROOS, Martin; SCHAEFLEIN, Stephan; AUGENSTEIN, Rolf
    • The invention relates to a plant for carrying out chemical reactions, having a reactor (1), the reaction space of which contains hydrogen peroxide (H2O2) and titanium silicalite (TS-1). The object of the invention is to improve such a plant such that continuous separation and recycling of the active catalyst to the reaction space is possible with a long filter service life. This is achieved in that the reaction space contains a solid silicon source, in that the ...
    ]]>     20100063323     <![CDATA[NOVEL POLYAMINE DERIVATIVES]]> http://www.patentstorm.us/applications/20100063322/description.html
  • Application Number:  20100063322
  • Publication Date:  2010-03-11
  • Inventors:  Masuko, Takashi; Miyake, Muneharu; Kusama, Tadashi
    • A compound having the general formula (I) or a pharmacologically acceptable salt thereof:


    X—NH—Y—NH—R1  (I)

    [wherein

      • X represents R2—SO2— in which R2 represents an optionally substituted ...
        ]]> 20100063322 <![CDATA[Process for Urea Production and Related Plant]]> http://www.patentstorm.us/applications/20100063321/description.html
      • Application Number:  20100063321
      • Publication Date:  2010-03-11
      • Inventors:  Zardi, Federico; Brunengo, Paolo; Sticchi, Paolo
      A process for urea production from ammonia and carbon dioxide, in which part of the aqueous solution comprising urea, ammonium carbamate and ammonia obtained in a urea synthesis section is subjected to dissociation in a treatment section operating at a predetermined medium pressure for the recovery of the ammonium carbamate and of the ammonia contained in it, comprises the steps of subjecting the urea aqueous solution resulting from the aforementioned dissociation step to decomposition in a low ...
      ]]> 20100063321 <![CDATA[ALCOHOL PRODUCTION METHOD BY REDUCING ESTER OF LACTONE WITH HYDROGEN]]> http://www.patentstorm.us/applications/20100063294/description.html
    • Application Number:  20100063294
    • Publication Date:  2010-03-11
    • Inventors:  KURIYAMA, Wataru; Ino, Yasunori; Ogata, Osamu
    Provided is an alcohol production method comprising the step of reducing an ester or a lactone with hydrogen to produce a corresponding alcohol without addition of a base compound by using, as a catalyst, a ruthenium complex represented by the following general formula (1):


    RuH(X)(L1)(L2)n   (1)

    wherein

    • ]]> 20100063294 <![CDATA[PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND]]> http://www.patentstorm.us/applications/20100063293/description.html
    • Application Number:  20100063293
    • Publication Date:  2010-03-11
    • Inventors:  Koyanagi, Toru; Kanbayashi, Shigehisa; Tanimura, Toyoshi; Yamamoto, Kazuhiro; Yoneda, Tetsuo; Taguchi, Yohei; Yoshida, Tatsunori
    To provide a process for producing a specific anthranilamide compound or its salt.

    To provide a process for producing an anthranilamide compound represented by the formula (I) or its salt:

    wherein each of R1a and R3 which are independent of each other, is halogen or haloalkyl; R2 is cyclopropyl alkyl or cyclobutyl alkyl; and Hal is a chlorine atom or a bromine atom, which ...
    ]]> 20100063293 <![CDATA[PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES]]> http://www.patentstorm.us/applications/20100063287/description.html

  • Application Number:  20100063287
  • Publication Date:  2010-03-11
  • Inventor:  Annis, Gary David
    • Disclosed is a method for preparing a compound of Formula 1 comprising (1) contacting a compound of Formula 2, with (2) at least one alkali metal cyanide and (3) at least one compound of Formula 4

    wherein R1 is NHR3 or OR4; R2 is CH3 or Cl; R3 is H, C1-C4 alkyl, cyclopropyl, cyclopropylcyclopropyl, cyclopropylmethyl or methylcyclopropyl; R4 ...
    ]]> 20100063287 <![CDATA[Catalyst for Dealcoholization Condensation Reaction and Method for Producing Organopolysiloxane Using the Same]]> http://www.patentstorm.us/applications/20100063236/description.html

  • Application Number:  20100063236
  • Publication Date:  2010-03-11
  • Inventors:  Sugiura, Yasushi; Sakai, Masanori
    • In the present invention, when an organopolysiloxane is produced by a dealcoholization condensation reaction between a silicon atom-bonded hydroxy group and a silicon atom-bonded alkoxy group, a quaternary ammonium ion-containing compound such as an alkylammonium hydroxide compound or a silanolate thereof is used as a catalyst. The catalyst for the dealcoholization condensation reaction of the present invention is easily removed after use and is stable. For this reason, when an ...
    ]]>     20100063236     <![CDATA[POLYMORPHS OF O-DESMETHYL VENLAFAXINE SUCCINATE]]> http://www.patentstorm.us/applications/20100063160/description.html
  • Application Number:  20100063160
  • Publication Date:  2010-03-11
  • Inventors:  Gore, Vinayak G.; Kulkarni, Vikas S.; Wakchaure, V.S.; Hublikar, M.G.; Wavhal, S.R.
    • The present invention relates to crystalline forms of O-desmethyl venlafaxine (ODV) succinate monohydrate, namely Forms I and II, in pure form and to novel processes for their preparation. The present invention provides a process for the preparation of Form II free of Form I and a process for the preparation of Form I free of Form II. The present invention provides direct methods for the preparation of ODV succinate Form II from ODV free base and for the preparation of ODV succinate Form I from ...
    ]]>     20100063160     <![CDATA[CHEMICAL PROCESS AND NEW CRYSTALLINE FORM]]> http://www.patentstorm.us/applications/20100063157/description.html
  • Application Number:  20100063157
  • Publication Date:  2010-03-11
  • Inventor:  CAINE, Darren Michael
    • The present invention relates to the preparation of a β2 adrenergic agonist in crystalline salt form. In particular the invention relates to preparation of a crystalline salt of compound (I)

    in particular a crystalline monohydrochloride salt. The invention also relates to a new crystalline form (polymorph) of the monohydrochloride salt of compound (Ia) and a process for preparing ...
    ]]> 20100063157 <![CDATA[ANANDAMIDE]]> http://www.patentstorm.us/applications/20100063156/description.html

  • Application Number:  20100063156
  • Publication Date:  2010-03-11
  • Inventor:  Streekstra, Hugo
    • The present invention describes provides the use of anandamide for the manufacture of a nutraceutical for oral intake preferably a medicament for reducing appetite, giving a satiety effect, preventing or reducing inflammatory bowel disease or preventing or reducing irritable bowel ...
    ]]>     20100063156     <![CDATA[N-(3-PHENYLPROPYL)BENZAMIDE DERIVATIVES]]> http://www.patentstorm.us/applications/20100063155/description.html
  • Application Number:  20100063155
  • Publication Date:  2010-03-11
  • Inventors:  Ort, Oswald; Coqueron, Pierre-Yves; Grosjean-Cournoyer, Marie-Claire; Mattes, Amos; Mansfield, Darren James; Hartmann, Benoit; Kunz, Klaus; Fischer, Ruediger; Gaertzen, Oliver
    • A compound of general formula (I):

    Also disclosed is a process for preparing this compound, a fungicidal composition comprising a compound of general formula (I), as well as a method for treating plants by applying a compound of general formula (I) or a composition comprising ...
    ]]> 20100063155 <![CDATA[POLYMORPHS OF ACYL SULFONAMIDES]]> http://www.patentstorm.us/applications/20100063154/description.html

  • Application Number:  20100063154
  • Publication Date:  2010-03-11
  • Inventors:  Davidson, James Prentice; Pang, Fei; Wong, Margaret; Martin, Michael
    • The application discloses novel polymorphic crystalline forms of 2-[4-Bromo-3-(3-chloro-5-cyano-phenoxy)-2-fluoro-phenyl]-N-(2-chloro-4-propionylsulfamoyl-phenyl)-acetamide, sodium salt (Ib)

    with improved stability and physical properties which facilitate manufacturing, handling and formulating for treatment or prophylaxis of HIV mediated diseases, AIDS or ARC, in monotherapy or in combination ...
    ]]> 20100063154 <![CDATA[COMPOUNDS AND USES THEREOF]]> http://www.patentstorm.us/applications/20100063144/description.html

  • Application Number:  20100063144
  • Publication Date:  2010-03-11
  • Inventors:  Aboagye, Eric Ofori; Vigushin, David Michael; Vigushin, Wendy
    • There is provided a compound of formula (I) wherein R1a, R2a, R3, X1 to X6, a, b and c have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, inhibitors of HDAC enzyme activity, and thus, in particular, in the treatment of conditions where inhibition of HDAC enzyme activity is required.

    ]]> 20100063144 <![CDATA[POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF]]> http://www.patentstorm.us/applications/20100063135/description.html

  • Application Number:  20100063135
  • Publication Date:  2010-03-11
  • Inventors:  Shen, Yu; Hansen, Todd M.; Sarthy, Aparna V.; Dande, Prasad A.; Hubbard, Robert D.; Kohlbrenner, William E.; Li, Leiming; Tian, Lu; Wada, Carol K.; Zhao, Xiaobin
    • Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are ...
    ]]>     20100063135     <![CDATA[Endothelin receptor antagonists]]> http://www.patentstorm.us/applications/20100063076/description.html
  • Application Number:  20100063076
  • Publication Date:  2010-03-11
  • Inventor:  Harbeson, Scott L.
    • This invention relates to novel endothelin receptor antagonists, derivatives, acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by compounds that block the endothelin signaling pathway that leads to vasoconstriction and in particular those diseases or conditions beneficially treated by endothelin receptor ...
    ]]>     20100063076     <![CDATA[Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives]]> http://www.patentstorm.us/applications/20100063075/description.html
  • Application Number:  20100063075
  • Publication Date:  2010-03-11
  • Inventors:  Beerli, Rene; Renaud, Johanne; Gerspacher, Marc; Altmann, Eva; Weiler, Sven; Widler, Leo
    • A compound of formula (1): wherein R1, R2, R3 and Y are as defined herein, or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, useful for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable.

    ]]> 20100063075 <![CDATA[SUBSTITUTED ANILINE DERIVATIVES]]> http://www.patentstorm.us/applications/20100063044/description.html

  • Application Number:  20100063044
  • Publication Date:  2010-03-11
  • Inventors:  Tornoe, Christian Wenzel; Khanzhin, Nikolay; Watson, William Patrick; Ritzén, Andreas; Rottlãnder, Mario; Rodriguez Greve, Daniel
    • The present invention relates to aniline derivatives of formula I:

    wherein R1, R2, R3, R4, Z and q are as defined herein; or salts thereof and their ...
    ]]> 20100063044 <![CDATA[Anti-oxidants]]> http://www.patentstorm.us/applications/20100062955/description.html

  • Application Number:  20100062955
  • Publication Date:  2010-03-11
  • Inventor:  Nalesnik, Theodore E.
    • A dialkylanilino-cyclohexane compound useful as an antioxidant has the following formula I or formula II:

    wherein Ar1 and Ar2 can be the same or different and each is an alkylaromatic group; each of R1, R2, R3, and R4 is independently selected from hydrogen or CR7R8; each of R5, R6, and R7 is independently selected ...
    ]]> 20100062955 <![CDATA[BENZANILIDES WITH INSECTICIDAL ACTIVITY]]> http://www.patentstorm.us/applications/20100062937/description.html

  • Application Number:  20100062937
  • Publication Date:  2010-03-11
  • Inventors:  Shibuya, Katsuhiko; Wada, Katsuaki; Murata, Tetsuya; Shimojo, Eiichi
    • Benzanilides of the formula:

    in which X represents hydrogen, halogen, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl or C1-6 alkylsulfonyloxy; Y represents halogen or C1-6 alkyl; R1 represents C1-6 alkyl, C1-6 alkylthio C1-6 alkyl, C1-6 alkylsulfinyl-C1-6 alkyl or C1-6 ...
    ]]> 20100062937 <![CDATA[Detection of Histone Deacetylase Inhibition]]> http://www.patentstorm.us/applications/20100062465/description.html

  • Application Number:  20100062465
  • Publication Date:  2010-03-11
  • Inventors:  Bornmann, William G.; Maxwell, David S.; Ronen, Sabrina M.; Gelovani, Juri G.; Pang, Jihai; Pal, Ashutosh; Tong, William P.; Paz, Ashutosh; Sankaranarayanapillai, Madhuri
    • Provided are compositions and methods for intracellular detection of enzyme activity. One example of a composition is a histone deacetylase substrate comprising a compound of the following formula (I): One example of a method is a method for detecting histone deacetylase activity comprising introducing a compound according to formula (1) to a plurality of cells and monitoring the cells with magnetic resonance spectroscopy.

    ]]> 20100062465 <![CDATA[Novel fluorochromes for organelle tracing and multi-color imaging]]> http://www.patentstorm.us/applications/20100062460/description.html

  • Application Number:  20100062460
  • Publication Date:  2010-03-11
  • Inventors:  Xiang, Yuejun; Pande, Praveen; Patton, Wayne Forrest
    • Provided are compounds, methods and kits for identifying in cells of interest organelles including nuclei and a wide variety of organelles other than nuclei (non-nuclear organelles), as well as cell regions or cell domains. These compounds and methods can be used with other conventional detection reagents for identifying the location or position or quantity of organelles and even for distinguishing between organelles in cells of ...
    ]]>     20100062460     <![CDATA[METHODS FOR PROVIDING NEUROPROTECTION FOR THE ANIMAL CENTRAL NERVOUS SYSTEM AGAINST THE EFFECTS OF ISCHEMIA, NEURODEGENERATION, TRAUMA, AND METAL POISONING]]> http://www.patentstorm.us/applications/20100061959/description.html
  • Application Number:  20100061959
  • Publication Date:  2010-03-11
  • Inventors:  Frey II, William H.; Hanson, Leah Ranae Bresin; Panter, Samuel Scott
    • Methods and pharmaceutical compositions for providing neuroprotection to the animal central nervous system against the effects of ischemia, and neurodegeneration. Patients at risk for certain diseases or disorders that are associated with cerebral ischemia may benefit, e.g., those at risk for Alzheimer's disease, Parkinson's disease, Wilson's disease or stroke or those patients having head or spinal cord injury. Patients undergoing certain medical procedures that may result in ischemia may also ...
    ]]>     20100061959     <![CDATA[LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS]]> http://www.patentstorm.us/applications/20100061928/description.html
  • Application Number:  20100061928
  • Publication Date:  2010-03-11
  • Inventors:  Madelmont, Jean-Claude; Chezal, Jean-Michel; Moins, Nicole; Teulade, Jean-Claude; Chavignon, Olivier
    • The present invention relates to the use of a compound of formula (I):

      • in which
      • R1 represents a radionuclide,
      • Ar represents an aromatic nucleus,
      • m is an integer varying ...
        ]]> 20100061928 <![CDATA[METHOD FOR PRODUCING ETHYLENEAMINES]]> http://www.patentstorm.us/applications/20100056828/description.html
      • Application Number:  20100056828
      • Publication Date:  2010-03-04
      • Inventors:  Oftring, Alfred; Hugo, Randolf; Hahn, Thilo; Dahmen, Kirsten; Baumann, Katrin; Melder, Johann-Peter
      The invention relates to a process for preparing an ethylene amine mixture, which comprises hydrogenating an amino nitrile mixture comprising at least 30% by weight of aminoacetonitrile (AAN) and at least 5% by weight of iminodiacetonitrile (IDAN) in the presence of a catalyst. Ethylenediamine (EDA) and/or diethylenetriamine (DETA) and, if appropriate, further ethylene amines can be isolated from the ethylene amine mixtures ...
      ]]> 20100056828 <![CDATA[COMPOUNDS USEFUL FOR TREATING BIPOLAR DISORDERS]]> http://www.patentstorm.us/applications/20100056827/description.html
    • Application Number:  20100056827
    • Publication Date:  2010-03-04
    • Inventors:  Bialer, Meir; Yagen, Boris
    The invention relates to the use of valnoctamide (VCD) for the treatment of bipolar disorder and in particular for the treatment of the manic phase of the bipolar ...
    ]]>     20100056827     <![CDATA[Process for producing dispersible and conductive Nano Graphene Platelets from non-oxidized graphitic materials]]> http://www.patentstorm.us/applications/20100056819/description.html
  • Application Number:  20100056819
  • Publication Date:  2010-03-04
  • Inventors:  Zhamu, Aruna; Jang, Bor Z.
    • The present invention provides a process for producing nano graphene platelets (NGPs) that are both dispersible and electrically conducting. The process comprises: (a) preparing a pristine NGP material from a graphitic material; and (b) subjecting the pristine NGP material to an oxidation treatment to obtain the dispersible NGP material, wherein the NGP material has an oxygen content no greater than 25% by weight. Conductive NGPs can find applications in transparent electrodes for solar cells ...
    ]]>     20100056819     <![CDATA[SHAPED POROUS BODIES OF ALPHA-ALUMINA AND METHODS FOR THE PREPARATION THEREOF]]> http://www.patentstorm.us/applications/20100056816/description.html
  • Application Number:  20100056816
  • Publication Date:  2010-03-04
  • Inventors:  Serafin, Juliana G.; Bhasin, Madan M.; Wallin, Sten A.; Lakso, Steven R.
    • This invention relates to shaped porous bodies of alpha-alumina platelets which are useful as catalyst carriers, filters, membrane reactors, and preformed bodies for composites. This invention also relates to processes of making such shaped bodies and processes for modifying the surface composition of ...
    ]]>     20100056816